Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Design and development of peptide-targeted lipid nanoparticles for tissue-specific mRNA delivery

Abstract

Lipid nanoparticles (LNPs) are the leading non-viral platform for nucleic acid delivery; however, their clinical success has largely been restricted to the liver or local administration. Systemic extrahepatic delivery remains limited by barriers to tissue accumulation, uptake, and intracellular delivery. This dissertation investigates strategies to overcome these barriers by engineering LNP surface properties, peptide interactions, and RNA cargo to improve delivery to the brain and heart.First, we investigated systemic LNP delivery following traumatic brain injury (TBI), where transient blood–brain barrier dysfunction enables nanoparticle access to injured tissue. LNPs retained injured brain access for 48 h, while functional transfection increased with later administration despite similar accumulation. Functionalization with the neuron-targeting rabies virus glycoprotein (RVG) peptide increased the proportion of neurons transfected 7-fold, demonstrating that peptide ligands can redirect LNP cellular tropism within injured tissue.We next investigated polyethylene glycol (PEG) as a regulator of circulation, brain accumulation, and functional mRNA delivery. Increasing long-anchor DSPE-PEG prolonged circulation and enhanced injured brain accumulation but reduced transgene expression, demonstrating the PEG dilemma. To overcome this tradeoff, we engineered protease-responsive PEG-lipids containing a calpain-cleavable peptide linker designed to exploit elevated protease activity in injured brain. These formulations restored transfection suppressed by high PEG content in vitro and achieved robust, injury-specific brain expression following systemic administration while reducing expression in nearly all peripheral organs compared with conventional formulations. These findings demonstrate that disease-associated enzymes can spatially regulate LNP function.Finally, we extended peptide targeting to cardiac delivery. LNPs functionalized with a novel targeting peptide increased cardiomyocyte transfection ~7-fold compared with untargeted LNPs. Combining these targeted LNPs with in situ circularizing RNA increased the magnitude and persistence of cardiac expression while substantially reducing liver expression. YAP delivery promoted expansion of transfected cardiomyocytes, supporting potential cardiac regeneration.Together, this work demonstrates that effective extrahepatic nucleic acid delivery requires coordinated control over nanoparticle pharmacokinetics, tissue access, cellular tropism, and intracellular activity. By integrating peptide targeting, disease-responsive materials, and engineered RNA cargo, this dissertation establishes complementary strategies for improving the spatial and cellular specificity of systemically administered LNPs and provides a framework for next-generation nucleic acid delivery systems.

Main Content

This item is under embargo until November 2, 2028.